Bridging the gap: molecular mechanisms, regional activity and connectivity in headache disorders - Report - MDSpire

Bridging the gap: molecular mechanisms, regional activity and connectivity in headache disorders

  • By

  • Linda Kollenburg

  • Erkan Kurt

  • Wim Mulleners

  • Hisse Arnts

  • Christopher Louis Robinson

  • Janneke Poelen

  • Kaare Meier

  • Moises Dominguez

  • Sait Ashina

  • Kris Vissers

  • September 25, 2025

  • 0 min

Share

Molecular Mechanisms and Neural Connectivity in Headache Disorders

Overview

This review synthesizes molecular, regional brain activity, and connectivity data underlying migraine, cluster headache, paroxysmal hemicrania, hemicrania continua, and occipital neuralgia. It highlights the trigeminal nucleus caudalis as a central hub in headache pathophysiology and identifies atypical neural network patterns contributing to symptomatology and treatment challenges.

Background

Headache disorders affect nearly half the global population and significantly impair psychosocial functioning and quality of life. Chronic headache conditions such as migraine and cluster headache are associated with psychiatric comorbidities and rank among the top causes of worldwide disability. Despite multiple treatment options ranging from pharmacologic to neuromodulatory interventions, many patients experience suboptimal responses. Understanding the molecular and neural connectivity mechanisms is essential to improve therapeutic strategies and patient outcomes.

Data Highlights

The review includes analysis of 130 articles on molecular mechanisms and 97 articles on regional activity and connectivity patterns published between 1976 and 2024. Key molecular players identified include neuropeptides and neurotransmitters such as vasoactive intestinal peptide, glutamate, substance P, and serotonin within the trigeminal nucleus caudalis. Functional abnormalities were noted in pain processing regions and large-scale brain networks including the default mode, salience, and sensorimotor networks, correlating with clinical features like cortical spreading depression in migraine and attack rhythmicity in cluster headache.

Key Findings

  • The trigeminal nucleus caudalis is a central structure integrating neurochemical signals critical to headache pathophysiology.
  • Neuropeptides such as vasoactive intestinal peptide, glutamate, substance P, and serotonin contribute to sensitization and neuroinflammation in headache disorders.
  • Abnormal regional brain activity and connectivity in pain processing and large-scale networks underlie both common and disorder-specific headache symptoms.
  • Cortical spreading depression is a key mechanism in migraine, while rhythmic attack patterns and autonomic symptoms characterize cluster headache, paroxysmal hemicrania, and hemicrania continua.
  • Overlap in pathophysiology between occipital neuralgia and primary headache disorders suggests potential shared therapeutic targets.

Clinical Implications

Recognizing the central role of the trigeminal nucleus caudalis and associated neurochemical pathways can guide targeted pharmacologic interventions. Understanding atypical brain network connectivity patterns may inform the development of neuromodulatory therapies and personalized treatment approaches. Integrating molecular and connectivity insights can help address suboptimal treatment responses and improve management of complex headache disorders.

Conclusion

This comprehensive review bridges molecular and neural connectivity perspectives to deepen understanding of headache disorder pathophysiology. Such integrative insights are critical for advancing innovative and effective therapeutic strategies.

References

  1. Connecting the Dots: Molecular Mechanisms, Regional Activity, and Neural Connectivity in Headache Disorders -- 2024

Original Source(s)

Related Content